4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Alcohol Drinking in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, T; Sansuk, K; van Rijn, RM | 1 |
| Brissett, DI; van Rijn, RM; Whistler, JL | 1 |
2 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Alcohol Drinking
| Article | Year |
|---|---|
β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake.
Topics: Alcohol Drinking; Animals; Arrestins; Benzamides; beta-Arrestin 2; beta-Arrestins; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperazines; Receptors, Opioid, delta | 2016 |
Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety.
Topics: Alcohol Deterrents; Alcohol Drinking; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzamides; Diazepam; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Narcotic Antagonists; Piperazines; Quinolines; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid, delta; Substance Withdrawal Syndrome | 2010 |